Immunotherapy dispenses with tumor antigens
- 1 September 2004
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 22 (9), 1096-1098
- https://doi.org/10.1038/nbt0904-1096
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A simple method to cure established tumors by inflammatory killing of normal cellsNature Biotechnology, 2004
- In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor ImmunityCancer Research, 2004
- Monoclonal antibodies as therapeutic agents for cancerThe Lancet Oncology, 2004
- T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?Expert Review of Vaccines, 2004
- Immunotherapy of melanoma: the good news, the bad ones and what to do nextSeminars in Cancer Biology, 2003
- Current Developments in Cancer Vaccines and Cellular ImmunotherapyJournal of Clinical Oncology, 2003
- CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell helpNature Medicine, 1999
- The TRAIL to selective tumor deathNature Medicine, 1999
- Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumorsNature Medicine, 1997
- Enhancement of Antitumor Immunity by CTLA-4 BlockadeScience, 1996